The increase in antibiotic resistance related to microbial biofilms creates an urgent need to search for an alternative and active antimicrobial agent. Recently, nanoparticles have gained considerable attention from scientists due to their potent antimicrobial activity. In the present study, two endosymbiotic actinomycete strains were isolated from marine sponge Crella cyathophora by surface sterilization and incubation of sponge pieces on culture media selective for actinobacteria. The culture filtrate extracts, including the bacterial supernatants (F) and cell filtrate (C) of the two actinomycete strains, were used as the reducing agent for the green biosynthesis of silver nanoparticles. The as-prepared silver nanoparticles were characterized using dynamic light scattering, zeta-potential, UV-Vis spectroscopy, and transmission electron microscopy. The average particle size for synthesized silver nanoparticles was about ∼8.66 ± 2 to 35 ± 2 nm with monodisperse spherical-like shapes and polydispersed shapes, respectively. The synthesized silver nanoparticles exhibited significant antimicrobial activity toward pathogenic microbes, especially with P. aeruginosa and E. cloacae. The effect of silver nanoparticles on the growth curve dynamics of P. aeruginosa and E. cloacae showed that the slope of the bacterial growth curve continuously decreased with increasing nanoparticle concentration. Moreover, the antibiofilm activity of the silver nanoparticles was measured, and the results showed that the silver nanoparticles displayed high biofilm inhibition activity against P. aeruginosa, B. subtilis, and S. aureus. Furthermore, silver nanoparticles exhibited a low to moderate cytotoxic effect against hepatocellular carcinoma cancerous cells, which reflect its possible use in the biomedical field.

Syzygium aromaticum L. (S. aromaticum) used universally as a spice beside as one of classical Indian and Chinese medicine. It contains a variety of biologically active substances, one of them is eugenol which the main component, accounting for 81.1% of the clove oil. It used in traditional medicine as an antibacterial, antineoplastic, antiseptic, and analgesic agent. Previous studies reported its role within photochemical reactions and its antioxidant, anti-inflammatory, antiviral, and insecticidal properties, for that, eugenol listed as a promising candidate for the chemical scaffold for pharmaceuticals. The aim of the current study is evaluating of methanolic (80%) clove extract at room temperature in the sunlight (RS) and at low temperatures in the dark (DC) for their antibacterial and anticancer activity applied on different two cancer cell line types breast carcinoma cell line (MCF-7) and hepato-carcinoma cell line type (HePG-2). The results evaluated that both (DC) and (RS) have antibacterial activity against five multidrug-resistant (MDR) isolates. Extract (DC) of clove has a larger zone of inhibition against S. aureus, S. epidermidis, P. aeruginosa, K. pneumonia, and E. coli, with diameter 13, 20, 20, 21, and 15 mm, respectively, with MICs and MBCs of 6.25 mg/mL and 12.5 mg/ml for all isolates except S. aureus showed MIC at 12.5 mg/ml. On the other hand, extract (RS) exhibit zone of inhibition with diameter 17, 10, 15, 18, 17 mm, respectively, with MICs and MBCs of 12.5 mg/mL and 25 mg/ml for all isolates except S. aureus showed MIC at 25 mg/ml. Also, both (DC) and (RS) have cytotoxic activity against two cell lines with significant DNA fragmentation as an indicator of cell apoptosis. The cytotoxic concentration of (DC) with IC₅₀ values for MCF-7 started at 250 µg/ml and reached 46.7% but was 500 and 1000 µg/ml. toxicity reached 100%. Cytotoxicity of (RS) against mcf7 was found to be 48.25% at a concentration of 500 μg/ml, reaching 100% toxicity at the above concentrations 1000 µg/ml. For the HepG-2 cell line, the cytotoxic activity of (DC) was significant at 50.5% at a concentration of 250 µg/ml, whereas RS showed cytotoxic activity at 500 µg/ml with a value of 17.3%. These therapies for cancer and bacterial infections are all-natural and eco-friendly.

Multidrug-resistant (MDR) bacteria are acknowledged as one of the main factors contributing to chronic illnesses and fatalities globally. Numerous diseases, including bloodstream infections, pneumonia, urinary tract infections, and surgical site infections, can be brought on by MDR bacteria. Therefore, a crucial topic of continuing research is the development of a novel and different treatment for MDR microbial pathogens. This work is introduce an alternative method for elimination of MDR bacterial isolates which are causative agents of urinary tract infection among people in Egypt. In our study, we need a novel strategy to combat MDR bacteria by green-synthesized metal nanoparticles (MNPs). That is due to the ability of MNPs to penetrate the cell wall and the cell membrane of gram-positive and gram-negative bacteria. Clinical isolates of MDR bacteria had their antibiotic susceptibility assessed before being molecularly identified using 16 s rRNA, sequencing, and phylogenetic analysis. Also, genetic profiles of isolated strains were performed using ISSR and SDS-PAGE. Finally, characterized plant-mediated silver nanoparticles derived from lemon and pomegranate peel extracts were evaluated against isolated multidrug-resistant bacterial stains. In our present trial, one-hundred urine samples were collected from 71 females and 29 males complaining of UTI (urinary tract infection) symptoms. One-hundred microbial isolates were isolated, including 88-g negative and only 8-g positive bacteria in addition to four yeast isolates (Candida species). A total of 72% of the isolated bacteria showed MDR activity. The most prevalent MDR bacterial isolates (Escherichia coli, Pseudomonas aeruginosa, Acinetobacter baumannii, Enterococcus faecalis, and Klebsiella pneumoniae) were identified through 16S rDNA PCR sequencing as with accession numbers OP741103, OP741104, OP741105, OP741106, and OP741107, respectively. Lemon and pomegranate-mediated silver nanoparticles [Ag-NPs] were characterized by UV spectroscopy, FTIR, XRD, and TEM with average size 32 and 28 nm, respectively. Lemon and pomegranate-mediated silver nanoparticles [Ag-NPs] showed an inhibitory effect on the selected five MDR isolates at MIC 50 and 30 µg/mL, respectively. These common bacterial isolates were also genetically examined using ISSR PCR, and their total protein level was evaluated using SDS-PAGE, showing the presence of distinct genetic and protein bands for each bacterial species and emphasizing their general and protein composition as a crucial and essential tool in understanding and overcoming MDR behavior in UTI patients. Lemon and pomegranate-mediated silver nanoparticles [Ag-NPs] were found to have an inhibitory effect on MDR isolates. Therefore, the study suggests that [Ag-NPs] could be a potential treatment for MDR UTI infections caused by the identified bacterial species.

Background and Objectives: Urinary tract infections [UTIs] are considered the third most known risk of infection in human health around the world. There is increasing appreciation for the pathogenicity of Gram-positive and Gram-negative strains in UTIs, aside from fungal infection, as they have numerous virulence factors. Materials and Methods: In this study, fifty urine samples were collected from patients suffering from UTI. Among the isolates of UTI microbes, six isolates were described as MDR isolates after an antibiotic susceptibility test carried out using ten different antibiotics. An alternative treatment for microbial elimination involved the use of biosynthesized silver nanoparticles (AgNPs) derived from Solanum lycopersicum [S. cumin]. Results: The sizes and shapes of AgNPs were characterized through TEM imaging, which showed spherical particles in a size range of 35–80 nm, of which the average size was 53 nm. Additionally, the silver nanoparticles (AgNPs) demonstrated inhibitory activity against Staphylococcus aureus (OR648079), exhibiting a 31 mm zone of inhibition at a minimum inhibitory concentration (MIC) of 4 mg/mL and a minimum bactericidal concentration (MBC) of 8 mg/mL. This was followed by Aspergillus niger (OR648075), which showed a 30 mm inhibition zone at an MIC of 16 mg/mL and a minimum fungicidal concentration (MFC) of 32 mg/mL. Then, Enterococcus faecalis (OR648078), Klebsiella pneumoniae (OR648081), and Acinetobacter baumannii (OR648080) each displayed a 29 mm zone of inhibition at an MIC of 8 mg/mL and an MBC of 16 mg/mL. The least inhibition was observed against Candida auris (OR648076), with a 25 mm inhibition zone at an MIC of 16 mg/mL and an MFC of 32 mg/mL. Furthermore, AgNPs at different concentrations removed DPPH and H₂O₂ at an IC50 value of 13.54 μg/mL. Also, AgNPs at 3 mg/mL showed remarkable DNA fragmentation in all bacterial strains except Enterococcus faecalis. The phytochemical analysis showed the presence of different active organic components in the plant extract, which concluded that rutin was 88.3 mg/g, garlic acid was 70.4 mg/g, and tannic acid was 23.7 mg/g. Finally, AgNPs concentrations in the range of 3–6 mg/mL showed decreased expression of two of the fundamental genes necessary for biofilm formation within Staphylococcus aureus, fnbA (6 folds), and Cna (12.5 folds) when compared with the RecA gene, which decreased by one-fold when compared with the control sample. These two genes were submitted with NCBI accession numbers [OR682119] and [OR682118], respectively. Conclusions: The findings from this study indicate that biosynthesized AgNPs from Solanum lycopersicum exhibit promising antimicrobial and antioxidant properties against UTI pathogens, including strains resistant to multiple antibiotics. This suggests their potential as an effective alternative treatment for UTIs. Further research is warranted to fully understand the mechanisms of action and to explore the therapeutic applications of these nanoparticles in combating UTIs.